1. Home
  2. BOLT vs MLEC Comparison

BOLT vs MLEC Comparison

Compare BOLT & MLEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOLT
  • MLEC
  • Stock Information
  • Founded
  • BOLT 2015
  • MLEC 2008
  • Country
  • BOLT United States
  • MLEC Cayman Islands
  • Employees
  • BOLT N/A
  • MLEC N/A
  • Industry
  • BOLT Biotechnology: Pharmaceutical Preparations
  • MLEC Blank Checks
  • Sector
  • BOLT Health Care
  • MLEC Finance
  • Exchange
  • BOLT Nasdaq
  • MLEC Nasdaq
  • Market Cap
  • BOLT 10.4M
  • MLEC 10.1M
  • IPO Year
  • BOLT 2021
  • MLEC N/A
  • Fundamental
  • Price
  • BOLT $5.75
  • MLEC $0.66
  • Analyst Decision
  • BOLT Buy
  • MLEC
  • Analyst Count
  • BOLT 3
  • MLEC 0
  • Target Price
  • BOLT $47.50
  • MLEC N/A
  • AVG Volume (30 Days)
  • BOLT 39.8K
  • MLEC 276.5K
  • Earning Date
  • BOLT 11-11-2025
  • MLEC 10-28-2025
  • Dividend Yield
  • BOLT N/A
  • MLEC N/A
  • EPS Growth
  • BOLT N/A
  • MLEC N/A
  • EPS
  • BOLT N/A
  • MLEC N/A
  • Revenue
  • BOLT $4,167,000.00
  • MLEC N/A
  • Revenue This Year
  • BOLT N/A
  • MLEC $20.42
  • Revenue Next Year
  • BOLT N/A
  • MLEC $30.00
  • P/E Ratio
  • BOLT N/A
  • MLEC N/A
  • Revenue Growth
  • BOLT N/A
  • MLEC 170.36
  • 52 Week Low
  • BOLT $4.59
  • MLEC $0.63
  • 52 Week High
  • BOLT $14.36
  • MLEC $10.47
  • Technical
  • Relative Strength Index (RSI)
  • BOLT 52.63
  • MLEC 17.62
  • Support Level
  • BOLT $5.62
  • MLEC $0.63
  • Resistance Level
  • BOLT $6.38
  • MLEC $0.83
  • Average True Range (ATR)
  • BOLT 0.43
  • MLEC 0.10
  • MACD
  • BOLT 0.01
  • MLEC 0.02
  • Stochastic Oscillator
  • BOLT 41.53
  • MLEC 3.33

About BOLT Bolt Biotherapeutics Inc.

Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.

About MLEC Moolec Science SA

Moolec Science SA is a science-based ingredient company focused on producing real animal proteins in plants through Molecular Farming, a technology in the alternative protein landscape. Its purpose is to upgrade the taste, nutrition, and affordability of alternative protein products while building a more sustainable and equitable food system. The company has various products in its pipeline such as; TSP Valorasoy which is a soy protein product to produce vegetable proteins with texture and fibrousness similar to those of meat, Glaso, a safflower oil with high levels of gamma-linolenic acid, SPC2 which is a plant-based chymosin, YEEA1, an extract derived from a novel yeast biomass with specific properties, and others. The company's revenues arise from operations in Argentina.

Share on Social Networks: